The theoretical framework for dissolution of weak acid and weak base drug compounds in buffered media is well established. Therefore, this article is intended to provide a review of this framework and apply it to formulate buffered dissolution media based on ionic equilibrium conditions within the diffusion layer at the solid-liquid interface. The pH o in the microenvironment is identified as a singularly important parameter that reflects ionic interactions between dissolving drug and buffer at the solid-liquid interface. This article is focused on (1) formulating buffered dissolution media based on ionic equilibrium conditions at the solid-liquid interface, (2) identifying key physicochemical parameters for both drug and buffer that are relevant to buffer formulation, and (3) providing experimental and calculation-based methods to estimate the pH o at the solid-liquid interface. A shift in emphasis from relying solely on bulk buffer pH properties forms a basis for formulating buffered dissolution media and also provides insight into the physicochemical factors that affect the dissolution rate of the drug compound.
INTRODUCTION
T he importance of buffered aqueous media to dissolution testing is evidenced by the number of monographs in the United States Pharmacopeia-National Formulary where conditions for dissolution testing are given (1) . Buffer specification is typically in terms of buffer pH, buffer concentration, and chemical composition. These specifications focus on the bulk pH of the buffered medium and do not explicitly include the influence of the interaction between dissolving drug and buffer at the solid-liquid interface in the microenvironment.
Stippler (2) , Rohrs (3) , and Levis et al. (4) have emphasized the importance of formulating buffered dissolution media intended for dissolution testing of sparingly soluble weak acid or weak base drug compounds. Buffered aqueous medium affects the dissolution rate of a sparingly soluble weak acid or weak base drug due to ionic interactions between the drug and the buffer species in the microenvironment at the solid-liquid interface (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) ; however, the influence of the buffer can be affected by the self-buffering capacity of the dissolved drug in the microenvironment. The extent to which the buffer influences dissolution rate depends on the ionization constants of the buffer and drug, total molar concentration of the buffer and buffer capacity, concentration of buffer species reacting with the drug compound, total drug solubility, and solubility of the un-ionized form of the drug compound. The pH o at the solid-liquid interface directly reflects the interaction between dissolved drug and buffer and yields data needed to estimate the relative dissolution rate of the drug. The relative dissolution rate scales the value so that the minimum is 1 under pH o conditions where the compound is un-ionized. Relative dissolution rate values >1 reflect pH o conditions where solubility increases due to ionization of the compound.
Mass transport models applied to the dissolution of weak electrolytes in aqueous buffered media are well established. Therefore, the purpose of this article is to review and apply the principles from these models to formulate buffered dissolution media for weak acid and weak base drug compounds through an analysis of the interaction between drug and buffer at the solid-liquid interface. Specifically, this article centers around (1) formulating buffered dissolution media based on ionic equilibrium conditions at the solid-liquid interface, (2) identifying key physicochemical parameters for both drug and buffer that are relevant to buffer formulation, and (3) providing experimental and calculation-based methods to estimate the pH o at the solid-liquid interface.
Diagrammatic Representation of the Dissolution Process and Ionic Interactions in the Microenvironment
The dissolution of a weak electrolyte drug at the solidliquid interface can be represented by the model outlined by Higuchi et al. (6) . Figure 1 is compound in buffered dissolution medium where the drug dissolves at the solid-liquid interface (x = o) and then diffuses through the aqueous diffusion layer into the bulk solution (x = h). (Throughout this article, the subscript o refers to the microenvironment at the solid-liquid interface and the subscript h refers to the bulk solution.) The dissolution process at the solid-liquid interface will be affected by the interaction of the proton acceptor buffer species, B -, that is transported from the bulk solution into the diffusion layer where it reacts with the weak acid drug RCO 2 H (shown in the diagram as HA) to produce RCO 2 -(shown in the diagram as A -). The pH o is a reflection of the ionic equilibrium conditions at the solid-liquid interface and will affect the relative dissolution rate. A similar concentration profile can be constructed to represent the dissolution process for sparingly soluble weak base drug compounds. In the case of a weak base, the incoming reactive buffer species is a proton donor that interacts with RNH 2 to form RNH The ionic reaction that occurs between the weak acid drug compound, RCO 2 H, and the proton-accepting buffer species, B -, is given by
The equilibrium expression for this ionic reaction is (6, 8) 
where Case II: Weak Base Drug Compound, RNH 2 In the case of a weak base, the ionic reaction that occurs between the weak base drug compound, RNH 2 , and the proton-donating buffer species, HP, is given by
The equilibrium expression for this ionic interaction is given by
The concentration of P -in the microenvironment can be defined
, and the concentration of HP in the microenvironment can be defined as [HP] 
can be rewritten using these definitions as follows:
where C HPh and C P _ h are the molar concentrations of the un-ionized and ionized buffer species, respectively, in the bulk buffer solution. Equation 5 can be solved for [RNH 3 + ] o by completing the square to give
where
The quantities f P -h and f HPh are the fractions of C P -h and C HPh , respectively, in the bulk solution, and C Total is the total molar buffer concentration where
Equations 3 and 6 must be considered approximate since they assume that the diffusion coefficients for all diffusing species are equal. It is advisable to carry out calculations with eqs 3 and 6 using scientific notation and a multiple digit mantissa to avoid the sensitivity of the calculation to round-off error. • increasing values of K (i.e., K a buffer < K a drug for a weak acid and K a drug < K a buffer for a weak base); • increasing bulk concentrations of buffer species, C B -h , for a weak acid and increasing bulk concentrations of buffer species, C HPh , for a weak base; and • increasing total bulk buffer concentration, C Total , with a corresponding increase in buffer capacity.
Therefore, buffer K a , buffer composition, total buffer concentration, and buffer capacity can be used as parameters to influence the concentration of ionized species of a weak acid or a weak base drug compound at the solidliquid interface. In turn, the concentration of [RCO 2 -] o or [RNH 3 + ] o will influence the total solubility and relative dissolution rate.
Total Solubility and Relative Dissolution Rate for a Weak Acid and a Weak Base Drug Compound
The dissolution rate of a sparingly soluble weak electrolyte drug is proportional to the total solubility (6, 8) where the total solubility, S total , for a weak acid drug compound, RCO 2 H, in the microenvironment is defined by ] o is the hydrogen ion concentration at the solid-liquid interface. Equation 8 predicts that the total solubility will decrease when pH o > pK a drug and increase when pH o < pK a drug .
The relationship between total drug solubility and the dissolution rate for the un-ionized drug species, R u , is given by 
From eqs 9 and 10, the relative dissolution rate, R rel , is then defined as
Equations 9-12 are approximate since they assume that the diffusion coefficients for all diffusing species are equal. Equations 11 and 12 predict that the relative dissolution rate will be approximately 1 when pH o << pK a drug , in the case of a weak acid, and pH o >> pK a drug , in the case of a weak base. These equations also predict that the relative dissolution rate will increase when pH o > pK a drug for a weak acid and pH o < pK a drug for a weak base. As emphasized by Ozturk et al. (9) , the pH o in the microenvironment, not the bulk pH h , is the parameter that reflects the ionic interactions in the diffusion layer. Therefore, the prediction of the relative dissolution rate based on pH bulk may be inaccurate. This shift in emphasis from relying solely on bulk buffer properties forms a basis for formulating buffered dissolution media and provides insight into physicochemical factors that affect the relative dissolution rate of the drug compound, such as self-buffering capacity of sparingly soluble weak electrolyte drugs.
Self-Buffering Capacity of a Weak Acid or Weak Base Drug Compound in the Microenvironment
As shown in Figure 1 , a saturated solution of un-ionized drug, RCO Therefore, a weak acid or a weak base is able to contribute to its own pH o and self-buffering capacity in the microenvironment. Equations 13a and 13b show that pH o is influenced by both pK a drug and the solubility of the un-ionized drug. The self-buffering capacity increases with increasing solubility of the un-ionized species of the drug compound (10) . As a consequence of the self-buffering capacity of the drug compound, the relationship between pH o and pH bulk is an important aspect to consider in formulating a buffered dissolution medium for a weak acid or weak base drug compound. As noted by Mooney et al. (10) , pH o is expected to equal pH bulk only under conditions when the dissociation of the weak acid or weak base drug compound is suppressed or when the concentration of the reactive buffer species, a proton acceptor in the case of a weak acid or a proton donor in the case of a weak base, and total buffer concentration is sufficient to swamp the diffusion layer. Therefore, buffer concentration and composition are important parameters in determining the relationship between pH o and pH bulk . Since pH bulk cannot always be expected to equal pH o and since pH o directly affects the relative dissolution rate (9), methods to estimate pH o are needed.
Experimental and Calculation-Based Methods to Estimate [H + ] o and pH o Experimental Methods
Various experimental methods are available to determine pH o for weak electrolyte drugs including measuring the pH of the supernatant solution from a saturated solution of drug in buffer, pH indicator dyes in conjunction with diffuse reflectance visible spectroscopy, pH sensitive spin probes to assess microenvironmental pH, confocal microscopy to image pH sensitive fluorescent dyes, and micro pH probes (15) . Micro and surface pH electrodes have also been used to determine pH o for drug formulations, such as internally buffered drug formulations of furosemide (16), controlled-release formulations of telmisartan (17) , and tablet formulations of a poorly soluble weak base, isradipine (18) . ] o , such as the total buffer concentration and the concentration of buffer species C B -h in the case of a weak acid drug compound or the concentration of buffer species C HPh in the case of a weak base drug compound.
Calculation-Based Methods
One situation where equations used to estimate pH o would not be expected to provide a quantitative relationship occurs when there is an interaction between drug and buffer ingredients, such as with divalent cations or surfactants. Another situation occurs for a drug formulation where excipients may affect ionic equilibria in the microenvironment.
Experimental and Calculation-Based Values for pH o for a Weak Acid Drug Compound, Ibuprofen, and a Weak Base Drug Compound, Bupivacaine Case I: Weak Acid Drug Compound, Ibuprofen, in a Phosphate Buffer
Experimental pH o data in Table 1 were determined from the supernatant of saturated solutions of ibuprofen (ibuprofen USP Spectrum lot 2CHO353) dissolved in USP phosphate buffer systems of known concentration. The experimental pH o data in Table 2 were determined from saturated solutions of bupivacaine in 0.1 M phosphate buffers equilibrated at 37 °C (14 
SUMMARY
This article has focused on (1) formulating buffered dissolution systems based on the ionic interaction between drug and buffer at the solid-liquid interface, (2) identifying key physicochemical drug and buffer parameters relevant to buffer formulation, and (3) providing experimental and calculation-based methods to estimate pH o . An analysis of ionic equilibria in the diffusion layer predicts that the generation of ionized drug species is dependent on total buffer concentration and corresponding buffer capacity of the buffer as well as the concentration of either proton-accepting buffer species, C B -h , in the case of a weak acid drug compound, or proton-donating buffer species, C HPh , in the case of a weak base drug compound. The pK a of the buffer is another parameter that influences the production of ionized drug species. An analysis of the self-buffering capacity of the weak electrolyte drug compound indicates that total buffer concentration and buffer capacity are parameters that can be used to influence the relative dissolution rate. The pH o at the solid-liquid interface is identified as being singularly important in estimating the relative dissolution rate. Calculation-based methods to determine pH o are potentially useful to estimate the sensitivity of pH o to parameters such as total buffer concentration, the concentration of buffer species, and K a buffer . Experimental values for pH o determined under conditions of varying total buffer concentration and varying concentrations of buffer species are useful to confirm the sensitivity of pH o to these parameters and to provide data needed to estimate values for the relative dissolution rate. These data can then be used as a screening tool when developing buffered dissolution media that is related to unique physicochemical properties of the drug compound and drug formulation. 
